These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38636294)

  • 1. Vasopressor use and pressure injury risk. Only in the eye of the beholder?
    Mellinghoff J; Lin F; Blot S
    Intensive Crit Care Nurs; 2024 Aug; 83():103702. PubMed ID: 38636294
    [No Abstract]   [Full Text] [Related]  

  • 2. Pressure ulcer development and vasopressor agents in adult critical care patients: a literature review.
    Cox J
    Ostomy Wound Manage; 2013 Apr; 59(4):50-4, 56-60. PubMed ID: 23562874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Factors Are Associated With the Development of Pressure Ulcers in a Medical Intensive Care Unit?
    Smit I; Harrison L; Letzkus L; Quatrara B
    Dimens Crit Care Nurs; 2016; 35(1):37-41. PubMed ID: 26627071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Vasopressor Dose and the Incidence of Pressure Injuries in Critically Ill Patients.
    Holt KR; Short MR; Berger SC; McCalla AW
    Adv Skin Wound Care; 2022 Oct; 35(10):550-554. PubMed ID: 35866867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should Norepinephrine, Rather than Phenylephrine, Be Considered the Primary Vasopressor in Anesthetic Practice?
    Mets B
    Anesth Analg; 2016 May; 122(5):1707-14. PubMed ID: 27101504
    [No Abstract]   [Full Text] [Related]  

  • 6. Vasopressin for vasopressor-dependent septic shock.
    Szumita PM; Enfanto CM; Greenwood B; Wechsler ME
    Am J Health Syst Pharm; 2005 Sep; 62(18):1931-6. PubMed ID: 16141113
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk Factors for Pressure Injury Development Among Critical Care Patients.
    Cox J
    Crit Care Nurs Clin North Am; 2020 Dec; 32(4):473-488. PubMed ID: 33129408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surviving Sepsis Campaign guidelines 2008: revisiting vasopressor recommendations.
    Dünser MW; Dünser WR
    Crit Care Med; 2008 Aug; 36(8):2488; author reply 2488-9. PubMed ID: 18664827
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of vasopressor agents on the development of pressure ulcers in critically ill patients: a systematic review.
    McEvoy N; Patton D; Avsar P; Curley G; Kearney C; Clarke J; Moore Z
    J Wound Care; 2022 Mar; 31(3):266-277. PubMed ID: 35199593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Pressure Injuries in a Critical Care Unit in Lebanon: Prevalence, Characteristics, and Associated Factors.
    El-Marsi J; Zein-El-Dine S; Zein B; Doumit R; Kurdahi Badr L
    J Wound Ostomy Continence Nurs; 2018; 45(2):131-136. PubMed ID: 29521923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vasopressor administration in patients with acute neurologic injury.
    Muzevich KM; Voils SA
    Neurocrit Care; 2009; 11(1):112-9. PubMed ID: 19387871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early vasopressor use in critical injury is associated with mortality independent from volume status.
    Plurad DS; Talving P; Lam L; Inaba K; Green D; Demetriades D
    J Trauma; 2011 Sep; 71(3):565-70; discussion 570-2. PubMed ID: 21908995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasopressor drugs in shock due to myocardial infarction].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1967 Oct; 22(45):1744-7. PubMed ID: 4294154
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis.
    Owen VS; Rosgen BK; Cherak SJ; Ferland A; Stelfox HT; Fiest KM; Niven DJ
    Crit Care; 2021 Apr; 25(1):146. PubMed ID: 33863361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early vasopressor use following traumatic injury: a systematic review.
    Hylands M; Toma A; Beaudoin N; Frenette AJ; D'Aragon F; Belley-Côté É; Charbonney E; Møller MH; Laake JH; Vandvik PO; Siemieniuk RA; Rochwerg B; Lauzier F; Green RS; Ball I; Scales D; Murthy S; Kwong JSW; Guyatt G; Rizoli S; Asfar P; Lamontagne F
    BMJ Open; 2017 Nov; 7(11):e017559. PubMed ID: 29151048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressor support in septic shock.
    Hollenberg SM
    Chest; 2007 Nov; 132(5):1678-87. PubMed ID: 17998371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A literature review and meta-analysis of outcomes in microsurgical reconstruction using vasopressors.
    Knackstedt R; Gatherwright J; Gurunluoglu R
    Microsurgery; 2019 Mar; 39(3):267-275. PubMed ID: 30056632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasopressin as an alternative vasopressor in cardiopulmonary resuscitation. Study of the literature and comparison with adrenaline].
    Wenzel V; Padosch SA; Lindner KH
    Dtsch Med Wochenschr; 1998 Jul; 123(28-29):877-82. PubMed ID: 9693659
    [No Abstract]   [Full Text] [Related]  

  • 19. Identifying Vasopressor and Inotrope Use for Health Services Research.
    Fawzy A; Bradford M; Lindenauer PK; Walkey AJ
    Ann Am Thorac Soc; 2016 Mar; 13(3):414-8. PubMed ID: 26653145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension.
    Hylands M; Moller MH; Asfar P; Toma A; Frenette AJ; Beaudoin N; Belley-Côté É; D'Aragon F; Laake JH; Siemieniuk RA; Charbonney E; Lauzier F; Kwong J; Rochwerg B; Vandvik PO; Guyatt G; Lamontagne F
    Can J Anaesth; 2017 Jul; 64(7):703-715. PubMed ID: 28497426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.